Fabian Stiefel, Simon Fischer, M. Hackl, R. Handrick, F. Hesse, N. Borth, K. Otte, J. Grillari
{"title":"非编码RNA、转录后RNA操纵子与中国仓鼠卵巢细胞","authors":"Fabian Stiefel, Simon Fischer, M. Hackl, R. Handrick, F. Hesse, N. Borth, K. Otte, J. Grillari","doi":"10.4155/PBP.14.65","DOIUrl":null,"url":null,"abstract":"Chinese hamster ovary cells are among the biotechnologically most relevant production systems for biopharmaceuticals. With the availability of the genomic sequences of Chinese hamster, rational systems biotechnology-driven approaches to optimize this cell factory have become available. Here, we review the current status of noncoding RNAs as members of the post-transcriptional operon concept in the context of Chinese hamster ovary cell line engineering and bioprocessing. In addition, we suggest that they already now keep their promises as tools for increasing specific productivity and thus time space yield of biopharmaceutical production, a feature that will allow for more cost efficient production processes in the future.","PeriodicalId":90285,"journal":{"name":"Pharmaceutical bioprocessing","volume":"3 1","pages":"227-247"},"PeriodicalIF":0.0000,"publicationDate":"2015-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4155/PBP.14.65","citationCount":"14","resultStr":"{\"title\":\"Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells\",\"authors\":\"Fabian Stiefel, Simon Fischer, M. Hackl, R. Handrick, F. Hesse, N. Borth, K. Otte, J. Grillari\",\"doi\":\"10.4155/PBP.14.65\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chinese hamster ovary cells are among the biotechnologically most relevant production systems for biopharmaceuticals. With the availability of the genomic sequences of Chinese hamster, rational systems biotechnology-driven approaches to optimize this cell factory have become available. Here, we review the current status of noncoding RNAs as members of the post-transcriptional operon concept in the context of Chinese hamster ovary cell line engineering and bioprocessing. In addition, we suggest that they already now keep their promises as tools for increasing specific productivity and thus time space yield of biopharmaceutical production, a feature that will allow for more cost efficient production processes in the future.\",\"PeriodicalId\":90285,\"journal\":{\"name\":\"Pharmaceutical bioprocessing\",\"volume\":\"3 1\",\"pages\":\"227-247\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4155/PBP.14.65\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical bioprocessing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/PBP.14.65\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/PBP.14.65","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells
Chinese hamster ovary cells are among the biotechnologically most relevant production systems for biopharmaceuticals. With the availability of the genomic sequences of Chinese hamster, rational systems biotechnology-driven approaches to optimize this cell factory have become available. Here, we review the current status of noncoding RNAs as members of the post-transcriptional operon concept in the context of Chinese hamster ovary cell line engineering and bioprocessing. In addition, we suggest that they already now keep their promises as tools for increasing specific productivity and thus time space yield of biopharmaceutical production, a feature that will allow for more cost efficient production processes in the future.